Bilirubin, a potentially toxic catabolite of heme and indicator of hepatobiliary insufficiency,
exhibits potent cardiac and vascular protective properties. Individuals with Gilbert's …

The major issue in coronary heart disease (CHD) diagnosis and management is that
symptoms onset in an advanced state of disease. Despite the availability of several clinical …

Background Ischemia/reperfusion (I/R) injury causes overproduction of reactive oxygen
species, which are the major culprits of oxidative stress that leads to inflammation …

Circulating biomarkers available in clinical practice do not allow to stratify patients with
coronary heart disease (CHD) prior the onset of a clinically relevant event. We evaluated the …

Objective: Total bilirubin (TB) was recently recognized as an endogenous anti-inflammatory
and anti-oxidant molecule. Uric acid (UA) takes part in cardiovascular diseases by inducing …

Background: The potential antiatherogenic role of bilirubin is generally acknowledged, so
the aim of this study was to determine serum bilirubin concentrations and the prevalence of …

Background Bilirubin is a heme catabolism product with antioxidant, anti-inflammatory, and
anti-apoptotic properties and is implicated in the prognosis of several diseases. This study …

Bilirubin has traditionally been considered a cytotoxic waste product. However, recent
studies have shown bilirubin to have anti-oxidant, anti-inflammatory, vasodilatory, anti …

Objectives Previous studies have reported that serum total bilirubin provides some
protection against coronary artery disease (CAD); however, the relationship between serum …

Serum total bilirubin (STB) is a final product of heme metabolism. Many studies have shown
that bilirubin may protect against atherosclerosis due to its antioxidant properties [1–3] …